Design, synthesis, biological assessment and molecular docking studies of new 2-aminoimidazole-quinoxaline hybrids as potential anticancer agents

Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
Zahra GhanbarimasirMostafa Kardan

Abstract

In a search for novel antiproliferative agents, a series of quinoxaline derivatives containing 2-aminoimidazole (8a-8x) were designed and synthesized. The structures of synthesized compounds were confirmed by IR, 1H NMR, 13C NMR, Mass Spectroscopy and analyzed using HSQC, COSY, ROESY, HMBC techniques. The anticancer activity of all derivatives were evaluated for colon cancer and breast cancer cell lines by the MTT assay and acridine orange/ethidium bromide double staining method. The anti-cancer effect in human colon cancer (HCT-116) and breast cancer (MCF-7) cell lines exhibited that compounds 8a, 8s, 8t, 8w, 8x appeared as potent antiproliferative agents and especially inhibited the human colon cancer cell proliferation with percentage of inhibition by over 50%. The most active compound was (E)-4-phenyl-1-((quinoxalin-2-ylmethylene)amino)-1H-imidazol-2-amine (8a) with the highest inhibition for MCF-7 (83.3%) and HCT-116 (70%) cell lines after 48 and 24h, respectively. Molecular docking studies of these derivatives within c-kit active site as a validated target might be suggested them as appropriate candidates for further efforts toward more potent anticancer compounds.

Citations

Apr 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Aliya M S El NewahieKhaled A M Abouzid
Dec 5, 2018·European Journal of Medicinal Chemistry·M MontanaP Vanelle
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pankaj SharmaKarl A Werbovetz

❮ Previous
Next ❯

Related Concepts